IL6R and neoplasm: Accordingly, increased levels of soluble IL6R are observed in the lungs of tumor-bearing Gp130F/F;KrasG12D mice, and blocking this signaling pathway with an anti-IL6R antibody or the inhibitor sgp130Fc abrogates tumorigenesis in vivo [168].